Cure8 research brief
Cure8 research brief
This study suggests an environmental fungicide can disrupt gut microbes and reduce beneficial microbial tryptophan metabolites, promoting colitis in mice; dietary tryptophan reversed those effects in the model.
For people with IBD, the work highlights a possible link between environmental exposures, microbiome metabolism, and intestinal inflammation.
Researchers studying microbiome–immune interactions, environmental impacts on gut health, and AhR signaling; clinicians and patients interested in diet–microbiome influences on IBD and environmental triggers.
This mouse study reports that exposure to the fungicide metalaxyl altered gut microbial composition, reduced production of microbial tryptophan metabolites, and suppressed aryl hydrocarbon receptor (AhR) signaling, changes the authors link to colonic inflammation.
In mice genetically susceptible to IBD (IL‑10−/−), metalaxyl triggered severe colitis; dietary tryptophan supplementation in the study restored microbial tryptophan-derived metabolites, reactivated AhR signaling, improved barrier function, and reduced inflammation.
The experiments used wild-type and IL‑10 knockout mice and an integrated multi-omics approach (microbiome and metabolome profiling) plus machine learning; results are preclinical and mechanistic rather than clinical.
The paper highlights the gut microbiota–tryptophan–AhR axis as a mediator of an environmental pollutant’s enterotoxic effects and suggests dietary tryptophan may be protective in this model. This is an animal/basic-science report in Frontiers in Nutrition.
It can help researchers and clinicians think about environmental triggers and host–microbiome pathways relevant to IBD, but it does not provide evidence that the same effects occur in people or that dietary tryptophan is an effective treatment for patients.
Preclinical mouse study using IL‑10 knockout (IBD‑susceptible) and wild‑type mice with multi‑omics analysis. Results are mechanistic and not evidence that dietary tryptophan prevents or treats IBD in humans.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.